School of Medicine
Showing 51-60 of 81 Results
-
Jimbo Dickerson
Postdoctoral Medical Fellow, Oncology
Masters Student in Health Policy, admitted Autumn 2022
Fellow in Medicine
Resident in MedicineBioI am a medical oncology fellow with a clinical focus on breast cancer, and a research focus on examining cancer care delivery and resource allocation in both high- and low-income contexts. I am currently in my final year of fellowship, working on a Masters in health policy, and doing post-doctoral research on a T32 in the health policy department. My post-doctoral work is divided between domestic policy research, which focuses on analyzing cost and care variation, and global oncology projects, which concentrate on implementation and care delivery.
-
Swati DiDonato
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsClinical Research Team Member, Stanford Partnership in AI-Assisted Care
Co-Lead, Stanford Healthcare Value Based Care Academy -
Robert Diep, MD
Clinical Assistant Professor, Medicine - Hematology
BioDr. Diep is a board-certified, fellowship-trained hematologist with Stanford’s Hematology Program and Hematologic Cancer Program. He is also a clinical assistant professor with the Department of Medicine, Division of Hematology.
He diagnoses and treats patients with a wide range of nonmalignant hematology conditions. His special interests include clotting disorders, bleeding disorders, hemoglobinopathies, and disorders affecting blood count. Subspecialty interests include anticoagulation and thrombosis.
Dr. Diep’s practice style emphasizes shared decision-making by building patient-physician relationships and using the best available evidence to create treatment plans. He is passionate about improving care for patients with blood disorders and has helped expand access to hematology care by launching an electronic consult service for primary care providers.
Dr. Diep’s research interests include anticoagulation, thrombosis, and bleeding disorders. He has participated in research projects that have received funding from the National Heart, Lung, and Blood Institute.
Dr. Diep has published in multiple peer-reviewed journals, and has presented to his peers at national and regional meetings.
He is a member of the American Society of Hematology, American Society of Clinical Oncology, Hemostasis and Thrombosis Research Society, International Society of Hemostasis and Thrombosis, and Anticoagulation Forum. Dr. Diep serves as quality director for the Division of Hematology. -
Thomas Duane Dieringer
Clinical Assistant Professor, Medicine - Infectious Diseases
BioI have worked over the last 10 years to build a foundation for a career in academic infectious diseases by providing thoughtful dedicated care for my patients, conducting clinically focused research, and remaining an engaged educator for developing physicians. My passion for the study of infectious diseases has led me to complete a general infectious diseases fellowship and additional focused training in transplant and immunocompromised infectious diseases. I will continue to work diligently with my colleagues focusing on the growth of medical learners, advancing patient centered clinical research, and striving to provide the highest quality of care to patients.
-
Julie Ding
Clinical Assistant Professor, Medicine
BioJulie Ding is a Clinical Assistant Professor at Stanford School of Medicine. She received her medical degree from Touro University California, and then completed Internal Medicine residency at Highland Hospital in Oakland, California. Prior to medical training, she received her B.S. from University of California Berkeley. Her professional interests include clinical reasoning, high value care, and quality improvement.
-
Milana V. Dolezal, MD, MSci
Clinical Associate Professor, Medicine - Oncology
BioDr. Dolezal is a board-certified hematologist-oncologist with Stanford Medicine Cancer Center in Emeryville and a clinical associate professor in the Stanford School of Medicine, Division of Oncology.
She strives to work with patients to develop care plans that are comprehensive and personalized achieve the best possible outcomes and quality of life.
Dr. Dolezal also has extensive experience in research and drug development. She previously held positions as a clinical scientist, assistant medical director, and associate medical director in the BioOncology Therapeutics unit of the biotechnology company Genentech.
She has conducted clinical research into fertility preservation in patients with breast cancer, advanced treatments for triple-negative breast cancer, and patients’ adherence to anti-cancer therapy. She has co-authored articles on her research findings that appeared in the Journal of Clinical Oncology, Cancer, and other peer-reviewed publications.
She also co-authored the chapter “Progression from Hormone-Dependent to Hormone-Independent Breast Cancer” in the textbook Hormones, Genes and Cancer published by Oxford University Press.
Dr. Dolezal has made presentations to her peers at meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and European Cancer Organisation.
